ABT-267, ABT 333, ABT-450 and Ritonavir |
AbbVie |
June 2017 |
|
Bedaquiline (TMC207) |
Janssen Research & Development |
October 2019 |
|
Cemiplimab (REGN2810) - New |
Regeneron Pharmaceuticals, Inc. |
September 2021 |
|
Cenicriviroc Mesylate CVC (TBR-652) |
Allergan |
March 2020 |
|
Dapivirine (Vaginal Ring) |
International Partnership For Microbicides |
September 2021 |
|
Delamanid (OPC-67683) |
Otsuka |
June 2021 |
|
Dolutegravir (GSK1349572) |
ViiV Healthcare |
October 2021 |
|
Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) |
Merck |
July 2021 |
|
Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) |
Gilead Sciences |
December 2016 |
YES |
Glecaprevir (ABT-493) and Pibrentasvir (ABT-530) |
AbbVie |
December 2018 |
|
GSK1265744 (Cabotegravir) |
ViiV Healthcare |
January 2022 |
|
Letermovir |
Merck |
October 2021 |
|
Maraviroc (UK-427857) |
ViiV Healthcare |
December 2020 |
|
Pretomanid (PA-824) - New |
Global Alliance for TB Drug Development (TB Alliance) |
December 2021 |
|
Raltegravir (Isentress) |
Merck |
September 2017 |
YES |
Remdesivir (Veklury) |
Gilead Sciences |
June 2021 |
|
Rilpivirine (TMC278, Edurant) |
Janssen Research & Development |
July 2021 |
|
Sofosbuvir/Velapatasvir (Epclusa) |
Gilead |
July 2016 |
|
Tenofovir Alafenamide/Elvitegravir |
CONRAD |
July 2019 |
|
Tenofovir Gel |
CONRAD |
January 2013 |
|